1-3 of 3
Francesca Biondo, MD
Close
Sort by
Journal Articles

Decisional Flow with a Score System To Start Platelet-Lowering Treatment in Patients with Essential Thrombocythemia (ET): Long-Term Results.

Roberto Latagliata, MD, Angela Rago, MD, Antonio Spadea, MD, Cristina Santoro, MD, Ida Carmosino, MD, Massimo Breccia, MD, Laura Napoleone, MD, Angelo Fama, MD, Francesca Biondo, MD, Paola Volpicelli, MD, Maria Concetta Petti, PhD, Giuliana Alimena, PhD, Maria Gabriella Mazzucconi, PhD
Journal: Blood
Blood (2007) 110 (11): 4636.
https://doi.org/10.1182/blood.V110.11.4636.4636
Published: 2007
Journal Articles

Rituximab in Refractory Idiopathic Thrombocytopenic Purpura (ITP).

Cristina Santoro, MD, Francesca Biondo, MD, Gioia De Angelis, MD, Mariastefania De Propris, BD, Annalisa De Vellis, MD, Anna Guarini, BD, Luigi Malandruccolo, MD, Angela Rago, MD, Robert Foa, MD, Mariagabriella Mazzucconi, MD
Journal: Blood
Blood (2006) 108 (11): 3979.
https://doi.org/10.1182/blood.V108.11.3979.3979
Published: 2006
Journal Articles

Association of Hydroxyurea to Imatinib Is Effective in Patients with Chronic Myelogenous Leukemia Resistant to Imatinib Alone.

Roberto Latagliata, MD, Massimo Breccia, MD, Ida Carmosino, MD, Chiara Sarlo, MD, Rosa De Cuia, MD, Marco Mancini, MD, Francesca Biondo, MD, Eleonora Russo, MD, Annalisa De Vellis, MD, Daniela Diverio, MD, Franco Mandelli, PhD, Giuliana Alimena, PhD
Journal: Blood
Blood (2004) 104 (11): 4693.
https://doi.org/10.1182/blood.V104.11.4693.4693
Published: 2004